前往化源商城
入驻化源商城

品牌现货直购
供应商:我要出现这里





查看所有供应商和价格请点击:

969-33-5生产厂家

969-33-5价格

969-33-5

969-33-5结构式
969-33-5结构式
  • 常用中文名:盐酸赛庚啶
  • 常用英文名:cyproheptadine hydrochloride
  • CAS号:969-33-5
  • 分子式:C21H22ClN
  • 分子量:323.859
  • 相关类别: 原料药 抗变态反应药 抗组胺药
  • 发布时间:2018-03-10 08:00:00
  • 更新时间:2024-01-02 08:30:51
  • Cyproheptadine是5-HT2受体拮抗剂,IC50为0.6 nM。
  • 为H1受体拮抗剂,作用较氯苯那敏、异丙嗪强,并有中度抗5-羟色胺作用和抗胆碱作用。另外,临床发现,赛庚啶还有治疗流行性腮腺炎等多种新用途,研究表明盐酸赛庚啶的H1拮抗作用比扑尔敏强5倍以上。

化源商城直购

中文名 盐酸赛庚啶
英文名 cyproheptadine hydrochloride (anhydrous)
英文别名 4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine hydrochloride
Piperidine, 4- (5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methyl-, hydrochloride
periactinolhydrochloride
cyproheptadienehydrochloride
4-(5H-Dibenzo[a,d][7]annulen-5-yliden)-1-methylpiperidinhydrochlorid
4-(5H-dibenzo[a,d][7]annulén-5-ylidène)-1-méthylpipéridine chlorhydrate
piperidine, 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methyl-, hydrochloride
4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine Hydrochloride
CYPROHEPTADINE HCL BP
peritol
ANAREXOL
Cyproheptadin
Piperidine,4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methyl-, hydrochloride (1:1)
periactinhydrochloride
MFCD00012538
cyproheptadine hydrochloride
CYPROHEPTADINE HCL
EINECS 213-535-1
Piperidine, 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methyl-, hydrochloride (1:1)
periactinsyrup
4-(5H-Dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine hydrochloride (1:1)
nuran
1-Methyl-4-(5-dibenzo[a,e]cycloheptatrienylidene)piperidine hydrochloride
1-Methyl-4-(5H-dibenzo[a,e]cycloheptatrienylidene)piperidine Hydrochloride
Cyproheptadine (hydrochloride)
沸点 440.1ºC at 760mmHg
分子式 C21H22ClN
分子量 323.859
闪点 194.5ºC
精确质量 323.144073
PSA 3.24000
LogP 5.43780
外观性状 粉末
储存条件

保持容器密封,储存在阴凉,干燥的地方

稳定性

常温常压下稳定,避免强氧化剂接触

水溶解性 ethanol: soluble
分子结构

1、 摩尔折射率:91.59

2、 摩尔体积(m3/mol):257.5

3、 等张比容(90.2K):669.5

4、 表面张力(dyne/cm):45.6

5、 极化率(10 -24cm 3):36.31

计算化学

1.疏水参数计算参考值(XlogP):无

2.氢键供体数量:1

3.氢键受体数量:1

4.可旋转化学键数量:0

5.互变异构体数量:无

6.拓扑分子极性表面积3.2

7.重原子数量:23

8.表面电荷:0

9.复杂度:423

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:2

更多

1. 性状:未确定。

2. 密度(g/mL,25/4℃):未确定

3. 相对蒸汽密度(g/mL,空气=1):未确定

4. 熔点(ºC):未确定

5. 沸点(ºC,常压):未确定

6. 沸点(ºC,5.2kPa):未确定

7. 折射率:未确定

8. 闪点(ºC):未确定

9. 比旋光度(º):未确定

10. 自燃点或引燃温度(ºC):未确定

11. 蒸气压(kPa,25ºC):未确定

12. 饱和蒸气压(kPa,60ºC):未确定

13. 燃烧热(KJ/mol):未确定

14. 临界温度(ºC):未确定

15. 临界压力(KPa):未确定

16. 油水(辛醇/水)分配系数的对数值:未确定

17. 爆炸上限(%,V/V):未确定

18. 爆炸下限(%,V/V):未确定

19. 溶解性:溶于乙醇

毒理学数据:

1 、急性毒性:小鼠口经LD50: 69 mg/kg;大鼠LD50:295 mg/kg

2、 生殖毒性

大鼠生殖毒性试验:口经,母鼠怀孕后5-16天,60mg/kg。对胚胎和胎儿具有毒性作用(除了死亡,列入:抑制胎儿生长。)

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TM7050000
CHEMICAL NAME :
Piperidine, 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-methyl-, hydrochloride
CAS REGISTRY NUMBER :
969-33-5
LAST UPDATED :
199707
DATA ITEMS CITED :
14
MOLECULAR FORMULA :
C21-H21-N.Cl-H
MOLECULAR WEIGHT :
323.89
WISWESSER LINE NOTATION :
L C676 BYJ BU- DT6N DYTJ A1 &GH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
7 mg/kg/4W-C
TOXIC EFFECTS :
Gastrointestinal - other changes Liver - jaundice, cholestatic Liver - liver function tests impaired
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
295 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
52400 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
69 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
55300 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
107 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
23 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
216 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
60 mg/kg
SEX/DURATION :
female 5-16 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
250 mg/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Specific Developmental Abnormalities - homeostasis
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
40 mg/kg
SEX/DURATION :
female 13-20 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - endocrine system

MUTATION DATA

TYPE OF TEST :
Cytogenetic analysis
TEST SYSTEM :
Human Lymphocyte
DOSE/DURATION :
2200 umol/L/24H (Continuous)
REFERENCE :
ZEKIA5 Zeitschrift fuer Kinderheilkunde. (Berlin, Ger.) V.1-120, 1910-75. For publisher information, see EJPEDT. Volume(issue)/page/year: 118,219,1974 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X3187 No. of Facilities: 79 (estimated) No. of Industries: 1 No. of Occupations: 2 No. of Employees: 2047 (estimated) No. of Female Employees: 947 (estimated)

危害码 (欧洲) Xn: Harmful;
风险声明 (欧洲) R22;R36/37/38
安全声明 (欧洲) 26-36
危险品运输编码 UN 2811
WGK德国 3
RTECS号 TM7050000
包装等级 III
危险类别 6.1(b)
海关编码 2933399090
海关编码 2933399090
中文概述 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期
Summary 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%